Engage Therapeutics is focused on epilepsy patients suffering from uncontrolled seizures with what could be the first rescue treatment with the potential to stop their seizures. The company was acquired by UBC for up to US$270 million in June 2020.
Engage Therapeutics is focused on epilepsy patients suffering from uncontrolled seizures with what could be the first rescue treatment with the potential to stop their seizures. The company was acquired by UBC for up to US$270 million in June 2020.